Court orders FDA action on antibiotic use on farms

Court orders FDA action on antibiotic use on farms - USATODAY.com:

"In a ruling handed down Thursday, Judge Theodore Katz said the FDA must begin steps to withdraw approval of the two antibiotics for routine use in animals, siding with four consumer safety groups that brought a lawsuit against the agency.

"Today we take a long overdue step toward ensuring that we preserve these lifesaving medicines for those who need them most — people," said Avinash Kar, attorney for the Natural Resources Defense Council.
The court ruling will not immediately halt the use of antibiotics on farms. The FDA must first give drug companies a chance to respond and schedule a public hearing."

'via Blog this'

For more information, visit:
FDA - Animal and Veterinary - Antimicrobial Resistance

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog

Ouch! Black Box, Black Eye. Watch Out For These Antibotics.

• Trusted FDA cGMP online training programs and courses by SkillsPlus Intl Inc.

Updated March 19, 2022

The original link broke.

You can still read about the same topic here:

FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects - FDA.gov

---  the original post follows below  ---

 

Increased risk of tendinitis and tendon rupture - It's tough to be a drug company, and it's tough to be a patient taking medications. The FDA just released this alert, Information for Health Professionals - Fluoroquinolone Antimicrobial Drugs. So, if you're taking any of the following: Cipro, Proquin, Factive, Levaquin, Avelox, Noroxin, Floxin, or their myriad generically named brethren, then you should read the FDA release. This class of drugs just earned a black box warning, which means patients and prescribers should pay more attention to this unwanted effect. It's worth repeating the main thrust of the alert, "Fluoroquinolones are associated with an increased risk of tendinitis and tendon rupture. This risk is further increased in those over age 60, in kidney, heart, and lung transplant recipients, and with use of concomitant steroid therapy. Physicians should advise patients, at the first sign of tendon pain, swelling, or inflammation, to stop taking the fluoroquinolone, to avoid exercise and use of the affected area, and to promptly contact their doctor about changing to a non-fluoroquinolone antimicrobial drug." 

Return Home: http://drughealth.blogspot.com/